Pauline Lanting

Pauline Lanting, MSc, PharmD is a researcher at the University Medical Center Groningen's Faculty of Medicine, Department of Genetics. Her work focuses on pharmacogenetics, genetics, and COVID-19 research, with significant contributions to the Lifelines cohort study. She has published numerous articles in high-impact journals including American Journal of Human Genetics and Scientific Reports.

Her research interests span Pharmacogenetics, Genetics, COVID-19, SARS Coronavirus, Pharmacology, Personalized Medicine, Quality of Life, and Genetic Divergence. Dr. Lanting's work has made substantial contributions to understanding the genetic architecture of COVID-19 and developing practical applications of pharmacogenetic information for clinical use.

Her publication record shows a strong focus on translating genetic research into clinical applications, particularly in developing accessible pharmacogenetic testing methods and understanding the impact of SARS-CoV-2 on quality of life. Recent work includes developing low-cost pharmacogenetic passports and analyzing medication usage data from the Lifelines COVID-19 questionnaires.

Dr. Lanting has presented her research at numerous international conferences including the European Society of Human Genetics, Federation of European Academies of Medicine, and Human Genome Variation Society meetings. Her work has received media attention, particularly regarding patient-researcher collaboration in personalized medicine.